Search results
Here's What Key Metrics Tell Us About Wesco International (WCC) Q2 Earnings
For the quarter ended June 2026, Wesco International (WCC) reported revenue of $6.67 billion, up 13% over the same period last year. EPS came in at $4.57, compared to $3.39 in the year-ago quarter.
The Hanover Insurance Group, Inc. (THG) Hit a 52 Week High, Can the Run Continue?
A strong stock as of late has been Hanover Insurance Group (THG). Shares have been marching higher, with the stock up 7.2% over the past month. The stock hit a new 52-week high of $235.16 in the
Coastal Financial Q2 Earnings Call Highlights
Key Points
- Interested in Coastal Financial Corporation? Here are five stocks we like better.
- Coastal Financial reported a $42.1 million second-quarter GAAP net loss, primarily due to $68.8
Arxis Q2 Earnings Call Highlights
Key Points
- Interested in Arxis, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Sales rose 25% year over year to $501 million, while adjusted EBITDA increased 38% to $211
Amneal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Amneal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amneal reported strong Q2 results, with revenue up 10% to $796 million, adjusted EBITDA up 12% to
AMC Networks Q2 Earnings Call Highlights
Key Points
- Interested in AMC Networks Inc.? Here are five stocks we like better.
- AMC Networks raised its 2026 outlook after signing a five-year, $500 million co-exclusive Netflix licensing
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
Allegro MicroSystems Q1 Earnings Call Highlights
Key Points
- Interested in Allegro MicroSystems, Inc.? Here are five stocks we like better.
- Allegro reported strong fiscal Q1 results: Sales rose 27% year over year to $259 million, while non-GAAP
Agios Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Agios Pharmaceuticals, Inc.? Here are five stocks we like better.
- Mitapivat revenue reached $44.7 million in Q2 2026, while Agios reported a $100.7 million net loss
Symrise Q2 Earnings Call Highlights
Key Points
- Interested in Symrise AG? Here are five stocks we like better.
- Q2 momentum improved: Symrise reported €1.22 billion in second-quarter sales, with organic growth accelerating to 4.5%
Nemetschek Q2 Earnings Call Highlights
Key Points
- Interested in Nemetschek SE? Here are five stocks we like better.
- Strong first-half growth continued: Revenue increased 11.9% to €640.7 million, while recurring revenue rose 17.4% at
Drägerwerk AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Drägerwerk AG & Co. KGaA? Here are five stocks we like better.
- Drägerwerk delivered a strong first half of 2026: sales rose 7.7% to about €1.6 billion, EBIT more than
Wall Street Analysts See a 30.32% Upside in Banco Macro (BMA): Can the Stock Really Move This High?
Banco Macro (BMA) closed the last trading session at $90.8, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 28.32% Upside in Bunge Global (BG): Can the Stock Really Move This High?
Shares of Bunge Global (BG) have gained 2.8% over the past four weeks to close the last trading session at $107.78, but there could still be a solid upside left in the stock if short-term price
Do Options Traders Know Something About Advanced Energy Stock We Don't?
Investors in Advanced Energy Industries, Inc. AEIS need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 18, 2026 $90.00 Call had some of the
PCE Data for June: +3.3% on Core, Consumption & Pricing Higher
Thursday, July 30th, 2026Pre-market futures are building back a bit from Wednesday’s carnage following the latest press conference from Fed Chair Kevin Warsh, which itself followed the
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?
Investors in Edwards Lifesciences, Inc. EW need to pay close attention to the stock based on moves in the options market lately. That is because the August 21, 2026 $45.00 Call had some of the
TC Energy (TRP) Q2 Earnings and Revenues Surpass Estimates
TC Energy (TRP) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.59 per share a year ago. These figures
Seanergy Maritime Holdings Corp (SHIP) Q2 Earnings and Revenues Top Estimates
Seanergy Maritime Holdings Corp (SHIP) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $0.18 per share a
Red River Bancshares (RRBI) Q2 Earnings Beat Estimates
Red River Bancshares (RRBI) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $1.51 per share a year ago